Sequence variants of the TNFRSF13B gene in Czech CVID and IgAD patients in the context of other populations

Logo poskytovatele
Logo poskytovatele
Autoři

FREIBERGER Tomáš RAVČUKOVÁ Barbora GRODECKÁ Lucie PIKULOVÁ Z. ŠTIKAROVSKÁ D. PEŠÁK Sáva KUKLÍNEK Pavel JARKOVSKÝ Jiří SALZER U. LITZMAN Jiří

Rok publikování 2012
Druh Článek v odborném periodiku
Časopis / Zdroj Human Immunology
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
www http://dx.doi.org/10.1016/j.humimm.2012.07.342
Doi http://dx.doi.org/10.1016/j.humimm.2012.07.342
Obor Kardiovaskulární nemoci včetně kardiochirurgie
Klíčová slova TNFRSF13B (TACI); mutation; polymorphism; CVID; IgAD
Přiložené soubory
Popis Mutations in the TNFRSF13B gene, encoding TACI, have been found in common variable immunodefi- ciency (CVID) and selective IgA deficient (IgAD) patients, but only the association with CVID seems to be significant. In this study, Czech CVID, IgAD and primary hypo/dysgammaglobulinemic (HG/DG) patients were screened for all TNFRSF13B sequence variants. The TNFRSF13B gene was mutated in 4/70 CVID patients (5.7%), 9/161 IgAD patients (5.6%), 1/17 HG/DG patient (5.9%) and none of 195 controls. Eight different mutations were detected, including the most frequent p.C104R and p.A181E mutations as well as 1 novel missense mutation, p.R189K. A significant association of TNFRSF13B gene mutations was observed in both CVID (p = 0.01) and IgAD (p = 0.002) Czech patients. However, when combined with all published data, only the association with CVID remained significant compared with the controls (9.9% vs. 3.2%, p < 10^6), while statistical significance disappeared for IgAD (5.7% vs. 3.2%, p = 0.145). The silent mutation p.P97P was shown to be associated significantly with CVID compared with the controls in both Czech patients (allele frequency 4.3% vs. 0.2%, p = 0.01) and in connection with the published data (5.1% vs. 1.8%, p = 0.003). The relevance of some TNFRSF13B gene variants remains unclear and needs to be elu- cidated in future studies.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info